Exploring the nexus of nuclear receptors in hematological malignancies

被引：0
|
作者：
Mukesh Kumar Manickasamy
Anjana Sajeev
Bandari BharathwajChetty
Mohammed S. Alqahtani
Mohamed Abbas
Mangala Hegde
Babu Santha Aswani
Mehdi Shakibaei
Gautam Sethi
Ajaikumar B. Kunnumakkara
机构：
[1] Indian Institute of Technology Guwahati (IITG),Cancer Biology Laboratory, Department of Biosciences and Bioengineering
[2] King Khalid University,Radiological Sciences Department, College of Applied Medical Sciences
[3] University of Leicester,BioImaging Unit, Space Research Centre
[4] King Khalid University,Electrical Engineering Department, College of Engineering
[5] Ludwig-Maximilian-University,Chair of Vegetative Anatomy, Department of Human
[6] National University of Singapore,Anatomy, Musculoskeletal Research Group and Tumor Biology, Institute of Anatomy
[7] National University of Singapore,Department of Pharmacology, Yong Loo Lin School of Medicine
来源：
Cellular and Molecular Life Sciences | 2024年 / 81卷
关键词：
Hematological malignancies; Leukemia; Lymphoma; Multiple myeloma; Nuclear receptors; Differentiation; Apoptosis; Homeostasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Exploring the nexus of nuclear receptors in hematological malignancies
    Manickasamy, Mukesh Kumar
    Sajeev, Anjana
    BharathwajChetty, Bandari
    Alqahtani, Mohammed S.
    Abbas, Mohamed
    Hegde, Mangala
    Aswani, Babu Santha
    Shakibaei, Mehdi
    Sethi, Gautam
    Kunnumakkara, Ajaikumar B.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [2] Semaphorins and Their Receptors in Hematological Malignancies
    Wei, Li
    Li, Hongbo
    Tamagnone, Luca
    You, Hua
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [3] Role of leptin and leptin receptors in hematological malignancies
    Uddin, Shahab
    Mohammad, Ramzi M.
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 10 - 16
  • [4] Exploring Old Drugs for the Treatment of Hematological Malignancies
    Gan, F.
    Cao, B.
    Wu, D.
    Chen, Z.
    Hou, T.
    Mao, X.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (10) : 1509 - 1514
  • [5] Targeting nuclear import and export in hematological malignancies
    Boaz Nachmias
    Aaron D. Schimmer
    Leukemia, 2020, 34 : 2875 - 2886
  • [6] Targeting nuclear import and export in hematological malignancies
    Nachmias, Boaz
    Schimmer, Aaron D.
    LEUKEMIA, 2020, 34 (11) : 2875 - 2886
  • [7] The role of TRAIL death receptors in the treatment of hematological malignancies
    Henson, Elizabeth S.
    Johnston, James B.
    Gibson, Spencer B.
    LEUKEMIA & LYMPHOMA, 2008, 49 (01) : 27 - 35
  • [8] Exploring Big Data in Hematological Malignancies: Challenges and Opportunities
    Westin, Gustavo F.
    Dias, Ajoy L.
    Go, Ronald S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (04) : 271 - 279
  • [9] Exploring Big Data in Hematological Malignancies: Challenges and Opportunities
    Gustavo F. Westin
    Ajoy L. Dias
    Ronald S. Go
    Current Hematologic Malignancy Reports, 2016, 11 : 271 - 279
  • [10] Selective inhibitors of nuclear export (SINE) in hematological malignancies
    Das A.
    Wei G.
    Parikh K.
    Liu D.
    Experimental Hematology & Oncology, 4 (1)
12345